Trial · NCT01968967
Participant flow35
How many started, completed or left each group, period by period.
1 to 20 of 35
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period | STARTED | Placebo (Treatment Period) | 1,071 | |
| Treatment Period | STARTED | Bococizumab 150 mg (Treatment Period) | 1,068 | |
| Treatment Period | STARTED | Placebo (Extension Period) | 0 | |
| Treatment Period | STARTED | Bococizumab ADA Positive (Extension Period) | 0 | |
| Treatment Period | STARTED | Bococizumab ADA Negative (Extension Period) | 0 | |
| Treatment Period | Treated | Placebo (Treatment Period) | 1,065 | |
| Treatment Period | Treated | Bococizumab 150 mg (Treatment Period) | 1,063 | |
| Treatment Period | Treated | Placebo (Extension Period) | 0 | |
| Treatment Period | Treated | Bococizumab ADA Positive (Extension Period) | 0 | |
| Treatment Period | Treated | Bococizumab ADA Negative (Extension Period) | 0 | |
| Treatment Period | COMPLETED | Placebo (Treatment Period) | 925 | |
| Treatment Period | COMPLETED | Bococizumab 150 mg (Treatment Period) | 934 | |
| Treatment Period | COMPLETED | Placebo (Extension Period) | 0 | |
| Treatment Period | COMPLETED | Bococizumab ADA Positive (Extension Period) | 0 | |
| Treatment Period | COMPLETED | Bococizumab ADA Negative (Extension Period) | 0 | |
| Treatment Period | NOT COMPLETED | Placebo (Treatment Period) | 146 | |
| Treatment Period | NOT COMPLETED | Bococizumab 150 mg (Treatment Period) | 134 | |
| Treatment Period | NOT COMPLETED | Placebo (Extension Period) | 0 | |
| Treatment Period | NOT COMPLETED | Bococizumab ADA Positive (Extension Period) | 0 | |
| Treatment Period | NOT COMPLETED | Bococizumab ADA Negative (Extension Period) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01968967/flow